GUILLAIN-BARRE SYNDROME OCCURRENCE IN PATIENTS WITH FRONTAL EPILEPSY AND VASCULITIS


Cite item

Full Text

Abstract

Guillain-Barre syndrome (GBS) is an acute quickly progressing autoimmune disease of peripheral nervous system. Its etiology and pathogenesis are not studied till now and, therefore, remain the subject of discussions. In modern studies, the problems of comorbidity of this disease with different pathologies are discussed. The cases of simultaneous occurrence of GBS with myositis, transverse myelitis, mycoplasmal pneumonia are described. In this paper there is presented a case report on GBS occurrence in patients with frontal epilepsy and vasculitis. Marked immunocompomise of the body, participation of multiple viral-bacterial agents allows to speak about the available genetic predisposition to different types of immunopathological reactions, in particular GBS. The question of whether these diseases are comorbid or these are different processes needs further study, discussion and practical alertness in relation to these states.

About the authors

T M Prygunova

Нижегородская областная детская клиническая больница

Email: P-tanchita@yandex.ru
врач-невролог отделения для детей с поражением ЦНС и нарушением психики

E I Karpovich

Нижегородская областная детская клиническая больница

доктор медицинских наук, заведующая отделением методов нейрофизиологического обследования

M N Chernigina

Нижегородская областная детская клиническая больница

кандидат медицинских наук, заведующая детским областным противоэпилептическим центром

O D Elshina

Нижегородская областная детская клиническая больница

врач-невролог

E E Beresneva

Нижегородская областная детская клиническая больница

заведующая отделением для детей с поражением ЦНС и нарушением психики]

References

  1. Заболевания нервной системы у детей: в 2 т. Т. 2 / под ред. Ж. Айкарди и др.; пер. с англ.; общ. ред. А. А. Скоромца. - М.: Издательство Панфилова; БИНОМ. Лаборатория знаний 2013; 864-869.
  2. Студеникин В. М., Шелковский В. И., Пак Л. А., Турсунхужаева С. Ш., Гутнов С. Р. Человеческие иммуноглобулины для внутривенного введения в лечении синдрома Гийена-Барре у детей. Эффективная фармакотерапия. Педиатрия 2012; 2.
  3. Феничел Д. М. Педиатрическая неврология: основы клинической диагностики: пер. с англ. - М.: Медицина 2004; 324-325.
  4. Abend N. S., Bonnemann C. G., Licht D. J. Status epilepticus secondary to hypertensive encephalopathy as the presenting manifestation of Guillain-Barré syndrome. Pediatr. Emerg. Care 2007; 23 (9): 659-661.
  5. Aggarwal P., Sahoo R., Gadpayle A. K., Kumar G. Guillain-Barre syndrome in an adult patient with Henoch-Schonlein purpura. BMJ Case Rep 2013; 3. doi: 10.1136/bcr-2012-007945.
  6. Baxter R., Bakshi N., Fireman B., Lewis E., Ray P., Vellozzi C., Klein N. P. Lack of association of guillain-barré syndrome with vaccinations. Clinical Infectious Disiases 2013; 57 (2): 197-204. doi: 10.1093/cid/cit222.
  7. Fuchigami T., Hasegawa M., Hashimo-to K., Fujita Y., Inamo Y. Henoch-Schönlein purpura in a child with Guillain-Barré syndrome. Pediatr. Neurol. 2010; 43 (6): 431-434. doi: 10.1016/j.pediatrneurol.2010.06.008.
  8. Goraya J. S., Jayashree M., Ghosh D., Singh S., Singhi S. C., Kumar L. Guillain-Barré syndrome in a child with Henoch-Schönlein purpura. Scand. J. Rheumatol. 1998; 27 (4): 310-312.
  9. Liu C. T., Zhang G. Y., Wang G. L., Yin F. Clinical and electrophysiological characteristics, and prognosis of acute motor axonal neuropathy in children. Zhongguo Dang Dai Er Ke Za Zhi 2013; 15 (3): 192-195.
  10. Maneesh Kumar, Shrikiran Aroor, Suneel Mundkur, Sandeep Kumar. Guillain-Barré Syndrome: a clinical study of twenty children. J. Clin. Diagn. Res. 2015; 9 (1): SC09-SC12. doi: 10.7860/JCDR/2015/8344.5491.
  11. Mehndiratta M., Pandey S., Nayak R., Saran R. K. Acute onset distal symmetrical vasculitic polyneuropathy associated with acute hepatitis B. J. Clin. Neurosci. 2013; 20 (2): 331-332. doi: 10.1016/j.jocn.2012.03.029.
  12. Nortina Shahrizaila, Nobuhiro Yuki. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J. Neurol. Neurosurg. Psychiatry. 2013; 84: 576-583. doi: 10.1136/jnnp-2012-302824.
  13. Roca B., Ferrer D., Calvo B. Temporal arteritis and Guillain-Barré syndrome. South. Med. J. 2002; 95 (9): 1081-1082.
  14. Roodbol J., de Wit M.-C. Y., Aarsen F. K., Catsman-Berrevoets C. E., Jacobs.B. C. Long-term outcome of Guillain-Barré syndrome in children. J. Peripher. Nerv. Syst. 2014; 19 (2): 121-126. doi: 10.1111/jns5.12068.
  15. Tabor E. Guillain-Barré syndrome and other neurologic syndromes in hepatitis A, B, and non-A, non-B. J. Med. Virol. 1987; 21 (3): 207-216.
  16. Topcu Y., Bayram E., Karaoglu P., Yis U., Guleryuz H., Kurul S. H. Coexistence of myositis, transverse myelitis, and Guillain Barré syndrome following mycoplasma pneumoniae infection in an adolescent. J. Pediatr. Neurosci. 2013; 8 (1): 59-63. doi: 10.4103/1817-1745.111428.
  17. Van Doorn P.A. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS). Presse Med. 2013; 42 (6 Pt 2): e193-201. doi: 10.1016/j.lpm.2013.02.328.

Copyright (c) 2015 Prygunova T.M., Karpovich E.I., Chernigina M.N., Elshina O.D., Beresneva E.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies